Total neoadjuvant treatment (TNT) may offer a promising alternative to surgery for patients with stage I rectal cancer (S1RC) ...
In a licensing deal unveiled Monday, Lyell Immunopharma is handing over $40 million in cash and almost 2 million of its ...
Many cancer types — breast, prostate, skin cancer — have 5-year survival rates and ample treatment options if caught early.
Bowel-related symptoms persist for up to 5 years after colorectal cancer, and higher dietary fiber intake is associated with ...
Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...
LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...
January 28, 2008 (Orlando, Florida) — Patients without health insurance and those on Medicaid have a significantly higher risk of being diagnosed with advanced-stage colorectal cancer, according to ...
Colorectal surgeon Dr. Julio Garcia-Aguilar says there are a growing number of ways to treat colon and rectal cancer including advances in targeted therapy, surgery, and immunotherapy that can also ...
“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback